Providing a diverse range of perspectives from bullish to bearish, 12 analysts have published ratings on CME Group (NASDAQ:CME) in the last three months.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 1 | 6 | 4 | 1 | 0 |
Last 30D | 0 | 0 | 1 | 0 | 0 |
1M Ago | 0 | 1 | 0 | 0 | 0 |
2M Ago | 0 | 0 | 0 | 0 | 0 |
3M Ago | 1 | 5 | 3 | 1 | 0 |
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $281.25, a high estimate of $305.00, and a low estimate of $211.00. This upward trend is evident, with the current average reflecting a 3.72% increase from the previous average price target of $271.17.
The perception of CME Group by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
---|---|---|---|---|---|
Christopher Allen | Citigroup | Raises | Neutral | $275.00 | $265.00 |
Owen Lau | Oppenheimer | Raises | Outperform | $300.00 | $282.00 |
Alex Kramm | UBS | Raises | Buy | $305.00 | $290.00 |
Owen Lau | Oppenheimer | Raises | Outperform | $282.00 | $279.00 |
Mike Cyprys | Morgan Stanley | Raises | Overweight | $304.00 | $301.00 |
Kyle Voigt | Keefe, Bruyette & Woods | Raises | Market Perform | $273.00 | $265.00 |
Kenneth Worthington | JP Morgan | Lowers | Underweight | $211.00 | $223.00 |
Benjamin Budish | Barclays | Raises | Equal-Weight | $283.00 | $279.00 |
Owen Lau | Oppenheimer | Raises | Outperform | $279.00 | $269.00 |
Patrick Moley | Morgan Stanley | Raises | Overweight | $301.00 | $263.00 |
Patrick Moley | Piper Sandler | Raises | Overweight | $283.00 | $275.00 |
Benjamin Budish | Barclays | Raises | Equal-Weight | $279.00 | $263.00 |
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of CME Group's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
Stay up to date on CME Group analyst ratings.
Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P Dow Jones Indices, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.
Market Capitalization Highlights: Above the industry average, the company's market capitalization signifies a significant scale, indicating strong confidence and market prominence.
Revenue Growth: Over the 3M period, CME Group showcased positive performance, achieving a revenue growth rate of 10.38% as of 31 March, 2025. This reflects a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Financials sector.
Net Margin: CME Group's net margin excels beyond industry benchmarks, reaching 57.49%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): CME Group's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of 3.53%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): CME Group's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of 0.64%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: CME Group's debt-to-equity ratio is below the industry average at 0.13, reflecting a lower dependency on debt financing and a more conservative financial approach.
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. Click here to stay ahead of the market.
This article was generated by Benzinga's automated content engine and reviewed by an editor.